Patents by Inventor Andrea Galisova

Andrea Galisova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240009315
    Abstract: Particles having an ACE2 targeting moiety attached to an outer surface thereof are disclosed herein. The ACE2 targeting moiety comprises a polypeptide comprising an amino acid sequence of SARS CoV-2 receptor-binding domain (RBD), wherein said amino acid sequence comprises a modification at position 358 and at least two additional modifications at two positions selected from the group consisting of 484, 498 and 501. Uses of the particles for treatment and diagnosis of diseases are also disclosed.
    Type: Application
    Filed: August 2, 2023
    Publication date: January 11, 2024
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Gideon SCHREIBER, Jiri ZAHRADNIK, Amnon BAR-SHIR, Yinon RUDICH, Andrea GALISOVA
  • Patent number: 10617711
    Abstract: The invention relates to an antitumor composition based on hydrophobized hyaluronan and inorganic nanoparticles stabilized by oleic acid. The hydrophobized hyaluronan in the form of an acylated hyaluronan serves in the composition as a carrier of inorganic nanoparticles. Out of the group of inorganic nanoparticles, the composition may comprise superparamagnetic nanoparticles, nanoparticles of ZnO and moreover, upconversion nanoparticles. Said composition is selectively cytotoxic with respect to both suspension and adherent tumor cell lines, especially with respect to tumor cell lines of colorectum carcinoma and adenocarcinoma, lung carcinoma, hepatocellular carcinoma and breast adenocarcinoma. The highest cytotoxic effects were observed in case of the composition based on an oleyl derivative of hyaluronan with SPIONs. The composition of acylated hyaluronan with SPIONs may also be advantageously used for an in vivo detection of accumulation of the composition in the body, preferably in a tumor or in liver.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: April 14, 2020
    Assignee: Contipro a.s.
    Inventors: Daniela Smejkalova, Kristina Nesporova, Martina Tepla, Jakub Syrovatka, Gloria Huerta-Angeles, Martina Pospisilova, Vit Matuska, Jiri Mrazek, Andrea Galisova, Daniel Jirak, Vladimir Velebny
  • Publication number: 20170143756
    Abstract: The invention relates to an antitumor composition based on hydrophobized hyaluronan and inorganic nanoparticles stabilized by oleic acid. The hydrophobized hyaluronan in the form of an acylated hyaluronan serves in the composition as a carrier of inorganic nanoparticles. Out of the group of inorganic nanoparticles, the composition may comprise superparamagnetic nanoparticles, nanoparticles of ZnO and moreover, upconversion nanoparticles. Said composition is selectively cytotoxic with respect to both suspension and adherent tumor cell lines, especially with respect to tumor cell lines of colorectum carcinoma and adenocarcinoma, lung carcinoma, hepatocellular carcinoma and breast adenocarcinoma. The highest cytotoxic effects were observed in case of the composition based on an oleyl derivative of hyaluronan with SPIONs. The composition of acylated hyaluronan with SPIONs may also be advantageously used for an in vivo detection of accumulation of the composition in the body, preferably in a tumor or in liver.
    Type: Application
    Filed: June 30, 2015
    Publication date: May 25, 2017
    Inventors: Daniela Smejkalova, Kristina Nesporova, Martina Tepla, Jakub Syrovatka, Gloria Huerta-Angeles, Martina Pospisilova, Vit Matuska, Jiri Mrazek, Andrea Galisova, Daniel Jirak, Vladimir Velebny